• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名流感继发细菌感染患者出现心包积液的意外情况。

Unexpected Development of Pericardial Effusion in a Patient With Influenza and Secondary Bacterial Infection.

作者信息

Bahadoran Pooriya, Echeverria Daniel, Angammana Hansani, Nikollari Redi, Glass Lisa N

机构信息

Medicine, St. Barnabas Hospital Health System, Bronx, USA.

Internal Medicine, St. Barnabas Hospital Health System, Bronx, USA.

出版信息

Cureus. 2025 May 24;17(5):e84757. doi: 10.7759/cureus.84757. eCollection 2025 May.

DOI:10.7759/cureus.84757
PMID:40416904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12103259/
Abstract

Influenza poses a significant burden on healthcare systems worldwide, particularly when complicated by bacterial coinfections. Such cases often require intensive medical management. We present the case of a previously healthy young man whose influenza infection was complicated by bacterial coinfection, necessitating complex therapeutic intervention. During treatment with intrapleural fibrinolytic therapy, the patient was found to have developed a large pericardial effusion. While a causal relationship cannot be definitively established, this temporal association raises concern for a potential, previously unreported complication. We present this case to raise clinical awareness of this life-threatening possibility and encourage its consideration in the differential diagnosis when managing similar patients.

摘要

流感给全球医疗系统带来了沉重负担,尤其是在合并细菌感染时。此类病例通常需要强化医疗管理。我们报告一例既往健康的年轻男性病例,其流感感染合并细菌感染,需要进行复杂的治疗干预。在进行胸膜内纤维蛋白溶解治疗期间,发现该患者出现了大量心包积液。虽然无法明确建立因果关系,但这种时间上的关联引发了对一种潜在的、此前未报告的并发症的担忧。我们呈现此病例以提高对这种危及生命可能性的临床认识,并鼓励在处理类似患者时将其纳入鉴别诊断的考虑范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc13/12103259/774102b9e5f3/cureus-0017-00000084757-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc13/12103259/be10e068ae08/cureus-0017-00000084757-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc13/12103259/774102b9e5f3/cureus-0017-00000084757-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc13/12103259/be10e068ae08/cureus-0017-00000084757-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc13/12103259/774102b9e5f3/cureus-0017-00000084757-i03.jpg

相似文献

1
Unexpected Development of Pericardial Effusion in a Patient With Influenza and Secondary Bacterial Infection.一名流感继发细菌感染患者出现心包积液的意外情况。
Cureus. 2025 May 24;17(5):e84757. doi: 10.7759/cureus.84757. eCollection 2025 May.
2
Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.胸膜内纤维蛋白溶解疗法与安慰剂或不同的纤维蛋白溶解剂在治疗成人肺炎旁胸腔积液和脓胸中的比较。
Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD002312. doi: 10.1002/14651858.CD002312.pub4.
3
Intrapleural hemorrhage due to alteplase use in a 6-year-old boy with pleural effusion.胸腔积血患儿使用阿替普酶后出现胸腔内出血。
Int J Gen Med. 2013 Apr 12;6:233-6. doi: 10.2147/IJGM.S43783. Print 2013.
4
Retrospective analysis of large-dose intrapleural alteplase for complicated pediatric parapneumonic effusion and empyema.大剂量胸膜内注射阿替普酶治疗小儿复杂性类肺炎性胸腔积液和脓胸的回顾性分析
J Pediatr Pharmacol Ther. 2015 Mar-Apr;20(2):128-37. doi: 10.5863/1551-6776-20.2.128.
5
Intrapleural alteplase in a patient with complicated pleural effusion.一名复杂性胸腔积液患者的胸膜腔内注射阿替普酶治疗
Ann Pharmacother. 2003 Mar;37(3):376-9. doi: 10.1345/aph.1C248.
6
Intrapleural Fibrinolysis with Urokinase versus Alteplase in Complicated Pleural Effusions and Empyema: A Prospective Randomized Controlled Trial.尿激酶与阿替普酶用于复杂性胸腔积液和脓胸的胸膜内纤维蛋白溶解治疗:一项前瞻性随机对照试验
Tuberc Respir Dis (Seoul). 2024 Jul;87(3):378-385. doi: 10.4046/trd.2022.0168. Epub 2024 Mar 7.
7
A retrospective study to evaluate the safety and efficacy of intrapleural alteplase in pediatric empyema.回顾性研究评估胸腔内注射阿替普酶治疗小儿脓胸的安全性和有效性。
Przegl Epidemiol. 2024 Sep 18;78(2):145-149. doi: 10.32394/pe/189711. Epub 2024 Jun 7.
8
Efficacy and safety of intrapleural instillation of alteplase in the management of complicated pleural effusion or empyema.胸膜腔内注入阿替普酶治疗复杂性胸腔积液或脓胸的疗效与安全性。
Am J Ther. 2007 Jul-Aug;14(4):341-5. doi: 10.1097/01.mjt.0000208275.88120.d1.
9
Benefit of intrapleural fibrinolytic therapy in the treatment of complicated parapneumonic effusion and empyema.胸腔内纤维蛋白溶解疗法在治疗复杂性类肺炎性胸腔积液和脓胸中的益处。
Pan Afr Med J. 2024 Feb 8;47:54. doi: 10.11604/pamj.2024.47.54.15439. eCollection 2024.
10
Intrapleural streptokinase for the treatment of complicated parapneumonic effusion and empyema in 2 newborns.新生儿 2 例并发脓胸和肺炎旁胸腔积液应用胸腔内链激酶治疗。
J Pediatr Surg. 2012 Oct;47(10):e41-4. doi: 10.1016/j.jpedsurg.2012.07.034.

本文引用的文献

1
A case of hemothorax secondary to intrapleural fibrinolytic therapy: Considerations for use of fibrinolytics in high-risk patients.一例胸腔内纤维蛋白溶解疗法继发血胸:高危患者使用纤维蛋白溶解剂的考量
Respir Med Case Rep. 2021 May 1;34:101420. doi: 10.1016/j.rmcr.2021.101420. eCollection 2021.
2
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.全球季节性流感相关呼吸道死亡率的估计:一项建模研究。
Lancet. 2018 Mar 31;391(10127):1285-1300. doi: 10.1016/S0140-6736(17)33293-2. Epub 2017 Dec 14.
3
Seasonal Incidence of Symptomatic Influenza in the United States.
美国季节性流感的发病情况。
Clin Infect Dis. 2018 May 2;66(10):1511-1518. doi: 10.1093/cid/cix1060.
4
Estimating influenza disease burden from population-based surveillance data in the United States.根据美国基于人群的监测数据估算流感疾病负担。
PLoS One. 2015 Mar 4;10(3):e0118369. doi: 10.1371/journal.pone.0118369. eCollection 2015.
5
Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections.克林霉素和静脉注射免疫球蛋白的疗效及接触者发病风险在侵袭性 A 组链球菌感染中的作用。
Clin Infect Dis. 2014 Aug 1;59(3):358-65. doi: 10.1093/cid/ciu304. Epub 2014 Apr 29.
6
Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States.美国 2009 年大流行性流感病毒和细菌合并感染所致的重病。
Crit Care Med. 2012 May;40(5):1487-98. doi: 10.1097/CCM.0b013e3182416f23.
7
Intrapleural use of tissue plasminogen activator and DNase in pleural infection.胸腔内应用组织型纤溶酶原激活物和 DNA 酶治疗胸腔感染。
N Engl J Med. 2011 Aug 11;365(6):518-26. doi: 10.1056/NEJMoa1012740.
8
Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus.社区获得性呼吸道合并感染在重症 2009 年甲型流感病毒大流行患者。
Chest. 2011 Mar;139(3):555-562. doi: 10.1378/chest.10-1396. Epub 2010 Oct 7.
9
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.预防和控制流感的疫苗:免疫实践咨询委员会(ACIP)的建议,2010 年。
MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62.